Polyrizon Stock (NASDAQ:PLRZ)
Previous Close
$0.38
52W Range
$0.28 - $4.80
50D Avg
$0.71
200D Avg
$1.06
Market Cap
$1.60M
Avg Vol (3M)
$330.57K
Beta
-3.74
Div Yield
-
PLRZ Company Profile
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.